Buprenorphine Hydrochloride/Meloxicam

盐酸丁丙诺啡/美洛昔康

Report date: 2024/04/11 14:25:59

Base Information

Drug NameBuprenorphine Hydrochloride/Meloxicam
Drug Alias NameBT-205
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsCyclooxygenase-2 inhibitorsKappa opioid receptor antagonists +[4] 
TargetsCyclooxygenase-2Mu opioid receptorKappa opioid receptor +[4] 
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Buprenorphine HydrochlorideMeloxicam
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesBridge Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesBridge Therapeutics
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A